Healthtech company Biofourmis received $150 million from General Atlantic last week as part of a $300 million round announced recently, according to its regulatory filings.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
